Protocol: Benefits and harms of remdesivir for COVID-19 in adults: A systematic review with meta-analysis
Study Protocol
[키워드] adverse events
all-cause mortality
alleviate
analyses
approach
available data
benefit
Bia
Care
Clinical data
Clinical guidelines
clinician
Contact
COVID-19
death
decrease
drug treatment
eligible
Evidence
finding
Health
health care systems
help
Hospital stay
include
indication
information
less
Meta-analysis
morbidity and mortality
Patient
Placebo
Primary outcome
random-effect
Randomised trial
Regulatory
regulatory agencies
Remdesivir
resources
risk of bia
searched
secondary outcome
selective
Serious Adverse Events
severe disease
Severity of disease
shown
Sponsor
Standard of care
systematic review
Treatment
Trial
trials
website
[DOI] 10.1371/journal.pone.0260544 PMC 바로가기 [Article Type] Study Protocol
[DOI] 10.1371/journal.pone.0260544 PMC 바로가기 [Article Type] Study Protocol